Partial
Needs Review
Patient Risk:
Moderate
Summary
Most mechanistic and cardiovascular-risk statements align with the label, and several dosing/range details are correct; however, there is a definite contradiction for renal impairment dosing and multiple safety/interaction details are unsupported or incomplete relative to the provided labeling excerpts.
Category Scores
Accurate Statements
Lipitor is also known as atorvastatin.
11 DESCRIPTION
Lipitor is a statin medication that belongs to the HMG-CoA reductase inhibitor class.
11 DESCRIPTION; 12.1 Mechanism of Action
Lipitor works by blocking the production of cholesterol in the liver.
11 DESCRIPTION; 12.1 Mechanism of Action
Lipitor increases high-density lipoprotein (HDL) levels in the blood.
1.2 Hypeerlipidemia (increase HDL-C); 12.1 Mechanism of Action (variable increases in HDL-C)
Lipitor helps to reduce the risk of heart attacks.
1.1 Prevention of Cardiovascular Disease (reduce risk of myocardial infarction; includes non-fatal MI and fatal/non-fatal MI)
Lipitor helps to reduce the risk of strokes.
1.1 Prevention of Cardiovascular Disease (reduce risk of stroke; reduce risk of fatal and non-fatal stroke)
The dosage of Lipitor can range from 10 mg to 80 mg once daily.
2.1 Hyperlipidemia... (dosage range 10 to 80 mg once daily)
Lipitor may be combined with fibrates such as gemfibrozil.
2.4 Concomitant Lipid-Lowering Therapy (combination with fibrates should generally be used with caution); 12.3 Table 3 includes gemfibrozil
Potential side effects of Lipitor include muscle pain.
5.1 Skeletal Muscle (advised to report unexplained muscle pain; myopathy defined with muscle aches/weakness)
Patients with liver disease should consult with their healthcare provider before taking Lipitor.
5.2 Liver Dysfunction (use with caution in patients... history of liver disease)
Alternative treatment options may be necessary for patients with liver disease.
5.2 Liver Dysfunction (active liver disease/unexplained persistent transaminase elevations are contraindications)
Lipitor is metabolized in the liver.
12.3 Pharmacokinetics (metabolism; mentions hepatic first-pass and metabolism)
The Lipitor dosage may need to be adjusted when used in combination with other medications.
2.1 (dosage individualized/adjusted); 5.1 (lower starting/maintenance doses with certain interacting drugs); 7 Drug Interactions
Unsupported Statements
Lipitor may be combined with bile acid sequestrants such as cholestyramine.
Provided label excerpt states only 'may be used with bile acid resins' and does not specifically name cholestyramine.
Potential side effects of Lipitor include increased risk of diabetes.
This claim is not supported by the provided label sections.
Contradictions
High
AI Statement
Patients with severe renal impairment may require a lower dosage of Lipitor of 10 mg once daily.
Label Reference
2.5 Dosage in Patients With Renal Impairment (dosage adjustment in patients with renal dysfunction is not necessary).
Important Omissions
No mention of label-based monitoring for liver function tests (prior to and at 12 weeks after initiation and after dose increases, and periodically thereafter).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
A direct labeling contradiction exists regarding renal impairment dose reduction, and some safety/interaction-related statements are unsupported or incomplete versus the provided sections.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Needs Review
Primary Issue
Clinically significant contradiction: renal impairment dosing advice conflicts with label (dosage adjustment not necessary).
Suggested Improvement
Remove or correct the renal impairment dosing claim to match the label; avoid or qualify unsupported items (e.g., diabetes risk; cholestyramine specifically) unless supported by the complete label; include label monitoring language for liver function tests.